PRESS RELEASE published on 06/28/2024 at 09:00, 2 years 4 months ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 2 years 5 months ago CannaPharmaRx organisera une conférence téléphonique pour les investisseurs le 21 mai 2024 Mise À Jour Financière Conférence Téléphonique Pour Les Investisseurs Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 19:50, 2 years 5 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 2 years 5 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 2 years 5 months ago CannaPharmaRx organisera une conférence téléphonique avec les investisseurs Mise À Jour Financière Conférence Des Investisseurs CannapharmaRx Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 18:35, 2 years 5 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 2 years 5 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 2 years 7 months ago CannapharmaRx rembourse avec succès les billets convertibles pour renforcer sa position Remboursement De Dette Billets Convertibles CannapharmaRx Production De Cannabis Intérêts Des Actionnaires
BRIEF published on 04/02/2024 at 12:05, 2 years 7 months ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 2 years 7 months ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 11/03/2026 at 15:30, 1 hour 33 minutes ago Murchison Minerals Announces $1 Million Non-Brokered Private Placement
Published on 11/03/2026 at 15:05, 1 hour 58 minutes ago ACCESS Newswire to Host Third Quarter Earnings Conference Call on November 10, 2026
Published on 11/03/2026 at 14:31, 2 hours 32 minutes ago First Breach Adds Inspection Equipment and Secures Strategic Supply Agreements to Support Ammunition Production
Published on 11/03/2026 at 14:00, 3 hours 3 minutes ago Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Published on 11/03/2026 at 13:48, 3 hours 15 minutes ago EonX Announces Strategic Technology Partnership with Metcash, Australia's Leading Wholesaler and Service Provider to Independent Business Operators
Published on 11/03/2026 at 16:30, 33 minutes ago Shudao Investment Group Shines at the Global Panda Partners Conference 2026
Published on 11/03/2026 at 16:05, 58 minutes ago EQS-Adhoc: First Sensor AG: Change on the Supervisory Board
Published on 11/03/2026 at 16:00, 1 hour 3 minutes ago hep global and Engelhart sign one of Germany’s first full Hybrid PPAs
Published on 11/03/2026 at 15:37, 1 hour 26 minutes ago Alzchem Group AG focuses on continuity in sales: Martina Spitzer’s Management Board contract extended early through 2029
Published on 11/03/2026 at 11:30, 5 hours 33 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 11/03/2026 at 07:00, 10 hours 3 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/03/2026 at 07:00, 10 hours 3 minutes ago bioMérieux – Information financière du 3ème trimestre 2026
Published on 11/02/2026 at 21:08, 19 hours 55 minutes ago GROUPE SFPI : BILAN CONTRAT DE LIQUIDITE S1 2026
